Andrew Armstrong
Duke University, NC·Medicine & Clinical Research
Cancer clinical trials only help patients if they are well designed, can enroll enough people, and stay relevant as cancer care changes. This grant supports the Protocol Review and Monitoring Committee at the Duke Cancer Institute.
- Fields
Medicine & Clinical Research
Public Health & Epidemiology
- Topics
cancer clinical trials
oncology
protocol review
- Grants
- 1 known grant, through Dec 2029
What they work on
- Conduct a two-stage scientific review of all proposed cancer-related studies at the Duke Cancer Institute, covering study merit, feasibility, impact and fit for the relevant patient population before ethics board review.
- Monitor open studies against enrollment goals set by study type, rare-cancer status and patient representation, and close studies that fail to show meaningful progress.
- Train oncology fellows and junior faculty as scientific peer reviewers, and help study teams with study design and eligibility in collaboration with community outreach.
More about the research
The committee is the scientific peer-review body that judges whether cancer-related studies at the institute are sound before they open and whether they are making progress afterward.
Why it matters
Careful review and monitoring help ensure that cancer studies offered to patients are scientifically sound, feasible and relevant to the people they serve. By approving well-designed trials and closing ones that stall, the committee aims to direct patients and resources toward research that could improve cancer care. Its focus on patient representation helps make sure studies enroll the people the results are meant to help.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Lawrence Flaherty
Wayne State University, MI·Medicine & Clinical Research
Conduct a two-stage scientific review of cancer clinical trial protocols, first by multidisciplinary disease teams and then by the Protocol Review and Monitoring Committee, judging rationale, design, statistics and feasibility.
Jennifer Clarke
University of California-San Francisco, CA·Medicine & Clinical Research
Run disease- and discipline-focused site committees that give each proposed cancer clinical trial a first scientific review, judge its feasibility and expected enrollment, and set its priority.
Paul Crispen
University of Florida, FL·Medicine & Clinical Research
Support the development, activation, and regulatory compliance of investigator-initiated, NCI-sponsored, and industry cancer trials through a centralized Clinical Research Office at UF Health Cancer Center.
The school
Duke University: 61 labs on PI Pages, $1.6B a year on research, 417 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.